Orally Disintegrating Tablets

Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at Catalent Pharma Solutions

Related Content:

Solid/Semi-Solid DosageManufacturingDosage FormsManufacturing, Solid and Semi-Solid Dosage Drugs

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

AbbVie to Invest $195 Million in US API Manufacturing

Personalized and Patient-Centric Administration of Oral Medicines